Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAurobindopharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Pick Aurobindo Pharma, target Rs 770-780: Hemant Thukral

      Hemant Thukral of Aditya Birla Money is of the view that one can pick Aurobindo Pharma from the pharma space with a target of Rs 770-780.

    • Prefer Sun Pharma, LIC Housing, Infosys: Mayuresh Joshi

      Mayuresh Joshi of Angel Broking is of the view that one may prefer Sun Pharmaceutical, Infosys and LIC Housing Finance.

    • Buy Aurobindo Pharma: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Aurobindo Pharma.

    • Wockhardt traders pick, may test Rs 1550: Hemant Thukral

      According to Hemant Thukral of Aditya Birla Money, Wockhardt is a good traders pick and feels that it may test Rs 1550.

    • HDFC Bank, Infosys top picks; like L&T, IOC: R Sreeshankar

      According to R Sreesankar, Head - Institutional Equities at Prabhudas Lilladher, HDFC Bank and Infosys are the top picks and likes State Bank of India, ICICI Bank, Larsen & Toubro, Maruti Suzuki India, Tata Motors, IndusInd Bank and Indian Oil Corporation.

    • All weather stocks: 11 large caps to buy on market crash

      According to IIFL, dramatic fall in Indian equities recently, triggered by global sell‐off, offers a significant buying opportunity for investors. The best part is that one needn‘t go hunting for small gems as many blue‐chips are trading at attractive long‐term valuations.

    • Buy Aurobindo Pharma on declines: Mayuresh Joshi

      According to Mayuresh Joshi of Angel Broking, one may buy Aurobindo Pharma on declines for a target of Rs 872.

    • Super Six chart picks for September 1

      Meghana Malkan of malkansview.com is of the view that one may buy DLF with a target of Rs 119.

    • Buy Infosys, Sun Pharma, SBI, ICICI Bank, HDFC: Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Infosys, Sun Pharmaceutical Industries, State Bank of India, ICICI Bank, HDFC and Aurobindo Pharma.

    • Buy Divis Lab, Wockhardt; add Aurobindo Pharma: Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Divis Laboratories and Wockhardt and adding Aurobindo Pharma.

    • Invest in Infosys, SBI, Maruti, Sun Pharma, L&T: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can consider investing in Infosys, State Bank of India, ICICI Bank, Sun Pharmaceutical Industries, Maruti Suzuki, Larsen and Toubro, Housing Development Finance Corporation and Aurobindo Pharma.

    • Buy Cipla, Aurobindo Pharma: CA Rudramurthy

      CA Rudramurthy of Vachana Investments is of the view that one can buy Cipla and Aurobindo Pharma.

    • Aurobindo Pharma top pick, says Phani Sekhar

      P Phani Sekhar of Karvy Stock Broking is of the view that Aurobindo Pharma is the top pick from the pharma space.

    • Buy Aurobindo Pharma, UPL: Meghana Malkan

      Meghana Malkan of malkansview.com recommends buying Aurobindo Pharma and UPL.

    • Look at IT, healthcare space: Jonathan Schiessel

      Jonathan Schiessel of Asburton is of the view that one may look at IT and healthcare space.

    • Positive on pharma, like Aurobindo Pharma: Dipan Mehta

      Dipan Mehta, Member at BSE & NSE is extremely positive on the pharma industry but feels that Sun Pharma will underperform.

    • Super Six trading bets that can fetch you handsome returns

      Manas Jaiswal of manasjaiswal.com recommends buying Zee Entertainment for a target of Rs 430 and Motherson Sumi Systems for a target of Rs 366.

    • Buy Aurobindo Pharma 800 Call, sell 840 Call: VK Sharma

      VK Sharma of HDFC Securities is of the view that one can buy Aurobindo Pharma 800 Call and sell 840 Call.

    • Buy Aurobindo Pharma August futures: Manoj Murlidharan

      Manoj Murlidharan of Religare Securities advises buying Aurobindo Pharma August futures around Rs 767.

    • Bull's Eye: Buy NTPC, Cipla, Rolta, sell Reliance Infra

      Rakesh Bansal of RK Global suggets buying Gruh Finance with a target of Rs 258.

    • Bull's Eye: Buy Gruh Fin, JSPL, Voltas, Pidilite, DCB Bank

      According to Dharmesh Kant of India Nivesh Securities, one may buy Gateway Distriparks with a target of Rs 390.

    • Super Six trading ideas for the day

      Kunal Saraogi of Equityrush advises selling Tata Power with a target of Rs 64.

    • Phani Sekhar positive on largecap pharma space

      Phani Sekhar, Fund Manager--PMS at Karvy Stock Broking has a positive view on largecap pharma space.

    • Aurobindo Pharma, Glenmark Pharma top picks: R Sreesankar

      According to R Sreesankar, head - institutional equities at Prabhudas Lilladher, Aurobindo Pharma and Glenmark Pharma are the top picks.

    • Buy Aurobindo Pharma, may test Rs 1555: Sahil Kapoor

      Sahil Kapoor of Edelweiss Financial Services is of the view that one can buy Aurobindo Pharma as the stock can test Rs 1555 or head even higher.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347